R0

Revenio Group OyjMUN Revenio Group Stock Report

Last reporting period 31 Dec, 2023

Updated 21 Oct, 2024

Last price

Market cap $B

0.998

Micro

Exchange

XMUN - Boerse Muenchen

R0V.MU Stock Analysis

R0

Neutral

Based on Eyestock quantitative analysis, R0V.MU`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

66/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

42.5 %

Undervalued

Market cap $B

0.998

Dividend yield

1.44 %

Shares outstanding

26.58 B

Revenio Group Oyj engages in ophthalmic diagnostics and the manufacture and sale of ophthalmic devices. The company is headquartered in Vantaa, Etela-Suomen and currently employs 207 full-time employees. The company went IPO on 2003-01-01. The Company’s activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material handling systems. The company distributes products in a range of countries, including the United States, Canada, Australia, Japan and India. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others.

View Section: Eyestock Rating